NIH-funded research NIH-funded research

Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)

Official title: 1/2 GLobal trial Of Bromocriptine for PeriPartum CardioMyopathy (GLOBal PPCM)

Funded at University of Alabama at Birmingham · NIH-11625552 · Data updated 2026-11-12

A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 15, 2026
Project endAugust 31, 2033
Funding year2026
Award (this year)$31,320
NIH project number3UG3HL177574-01A1SB
Project IDNIH-11625552 on NIH RePORTER

Who could benefit from this research

Could help

Postpartum women diagnosed with peripartum cardiomyopathy, receiving standard heart-failure therapy, and who are eligible for bromocriptine as part of their clinical care.

Less likely to help

Patients who cannot tolerate bromocriptine or have contraindications may not benefit and could experience adverse effects.

What this research studies

This trial will enroll about 650 postpartum patients with PPCM across at least 18 sites in 15 low- and middle-income countries. Participants will be randomly assigned to receive either bromocriptine or a placebo, in addition to their usual heart failure treatment. The main goal is to see if the bromocriptine group has fewer deaths, better heart function, or fewer hospital readmissions at six months. Researchers will also carefully monitor safety for mothers and infants, including potential effects on lactation. The study is designed to provide clear evidence to guide care for PPCM patients worldwide.

Why it matters

Potential benefit: If successful, the approach could improve survival and heart function for women with PPCM and inform safer, standardized treatment guidelines.

How similar studies have gone: Preliminary small studies and animal data suggested potential benefits, but a large-scale trial is needed to confirm efficacy and safety.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Tita, Alan Thevenet N. — University of Alabama at Birmingham
  • Study coordinator: Tita, Alan Thevenet N.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.